Related Articles
Current and future perspectives in unresectable locally advanced esophageal squamous cell cancer (Review)
Combination of checkpoint inhibitors with radiotherapy in esophageal squamous cell carcinoma treatment: A novel strategy (Review)
Short‑ and long‑term outcomes of definitive chemoradiotherapy in patients with esophageal carcinoma aged ≥75 years
Neoadjuvant chemoradiotherapy followed by esophagectomy vs. surgery alone in the treatment of resectable esophageal squamous cell carcinoma
Bax expression as a prognostic marker of postoperative chemoradiotherapy for patients with esophageal cancer